Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Trogarzonon Aug 05, 2023 10:10am
124 Views
Post# 35574739

RE:RE:RE:RE:RE:50 cents and 50M market cap

RE:RE:RE:RE:RE:50 cents and 50M market capAnd shareholder gave them a pass at the last AGM. Even gave them the ok to increase the size of option plan.  Then when we voted 2 board members out almost at 50% vote Gary says chow line he's leaving on his own. Normally after a 50% drop in a stock like in dec.2022 and since the Q2 disaster and reverse sh..t you publicly adress the matter because let's face it it's a material event.  But no you call the company and you get an answering machine while they are somewhere else I guess.  All that to say that at 64 cents cdn or 48 cents usd whatever the reason you have to assume responsibility. They should be on the phone selling th1902 to offset this supposed seller that obviously has no intention of doing anything orderly.  The ongoing concern took a life of its own and everything to reassure shareholders should be put forward by BOD and management.  They are away enjoying the sun from what I understand while the house is burning. If it's not accurate like what we read from 5 analyst with like 10$ average target, do something about it. If management don't know what to do, we'll Mme Chairwomen do your job and find someone who can.
<< Previous
Bullboard Posts
Next >>